Globus Health-related (NYSE:GMED) and NuVasive (Nasdaq:NUVA) today introduced an settlement to mix in an all-inventory transaction. The deal values NuVasive at $3.1 billion, with Globus shareholders owning around three-fourths of the recently merged enterprise. BTIG analysts raised the question of…